Benitec Biopharma Limited Depreciation & Amortization Growth

Depreciation & Amortization Growth of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation & Amortization Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Depreciation & Amortization Growth for the quarter ending June 30, 2022 was -93.9% (a 546.25% increase compared to previous quarter)
  • Year-over-year quarterly Depreciation & Amortization Growth decreased by -174.13%
  • Annual Depreciation & Amortization Growth for 2022 was -27.71% (a -39.13% decrease from previous year)
  • Annual Depreciation & Amortization Growth for 2021 was -45.52% (a -136.96% decrease from previous year)
  • Annual Depreciation & Amortization Growth for 2021 was 123.16% (a -350.33% decrease from previous year)
  • Twelve month Depreciation & Amortization Growth ending June 30, 2022 was -2.7% (a -105.38% decrease compared to previous quarter)
  • Twelve month trailing Depreciation & Amortization Growth decreased by -113.37% year-over-year
Trailing Depreciation & Amortization Growth for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-2.7% 50.19% 46.56% 20.2%
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation & Amortization Growth of Benitec Biopharma Limited

Most recent Depreciation & Amortization Growthof BNTC including historical data for past 10 years.

Interactive Chart of Depreciation & Amortization Growth of Benitec Biopharma Limited

Benitec Biopharma Limited Depreciation & Amortization Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -93.9% -14.53% -27.71%
2021 67.31% 126.67% 146.0% -13.27% -45.52%
2020 -29.99% -11.76% -80.95% 87.5% -49.2%
2019 857.0% 70.0% 0.0%
2018 0.27%
2017 -22.49%
2016 425.0% 0.09%
2015 -46.67% 588.14%
2014 -89.55% -61.44%
2013 -41.18% 159.32%

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology